Exercise Interventions and Dietary Advice in Fibromyalgia and IBS
Launched by AZIENDA OSPEDALIERA SPECIALIZZATA IN GASTROENTEROLOGIA SAVERIO DE BELLIS · Apr 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how exercise and dietary advice can help people who have both Fibromyalgia (FM) and Irritable Bowel Syndrome (IBS). FM is a condition that causes widespread pain, fatigue, and sleep issues, while IBS affects the gut and can lead to stomach discomfort. The researchers want to see if physical activity and changes in diet can improve the symptoms of both conditions, which often occur together and share some common underlying issues.
To participate in this trial, individuals need to be between 30 and 65 years old, have a confirmed diagnosis of both FM and IBS, and have moderate to severe IBS symptoms. Participants should be healthy enough to stop any current treatments for their conditions temporarily. Those who join the study can expect to engage in various exercise programs and receive dietary guidance, with the aim of reducing their symptoms and improving their overall well-being. This trial is not yet recruiting participants, but it represents an important step in exploring non-drug treatments for these challenging conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of Irritable Bowel Syndrome (IBS) concomitant with Fibromyalgia (FM).Meeting the American College of Rheumatology (ACR) diagnostic criteria for FM and meeting the Rome III/IV diagnostic criteria for IBS.
- • Total score on the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) ≥ 125 (indicating moderate to severe IBS symptoms).
- • Men and women aged between 30 and 65 years.
- • Body Mass Index (BMI) between 18.5 and 29.9.
- Exclusion Criteria:
- • Individuals with severe cardiac, hepatic, neurological, psychiatric disorders, or other gastrointestinal diseases.
- • Individuals unable to discontinue symptom management therapies and medications for FM/IBS.
About Azienda Ospedaliera Specializzata In Gastroenterologia Saverio De Bellis
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio De Bellis is a leading healthcare institution dedicated to advancing the field of gastroenterology through innovative clinical research and patient-centered care. Renowned for its specialized services and comprehensive treatment options, the hospital is committed to improving patient outcomes and enhancing the understanding of gastrointestinal disorders. With a focus on rigorous clinical trials, the institution collaborates with multidisciplinary teams to explore new therapies and diagnostic methods, ensuring that it remains at the forefront of gastroenterological advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Castellana Grotte, Bari, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported